Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

| More on:
Overjoyed man celebrating success with yes gesture after getting some good news on mobile.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

Domain Holdings Australia Ltd (ASX: DHG)

According to a note out of Bell Potter, its analysts have upgraded this property listings company's shares to a buy rating with an improved price target of $3.30. This follows the release of a half year result which revealed a 27% increase in earnings per share. This was ahead of the market's expectations. The broker believes that this shows that Domain is repairing the damage to its audience and listings. It feels this could mean it is approaching the start of a potential consensus earnings upgrade cycle. The Domain share price is trading at $3.07 on Friday afternoon.

Pro Medicus Limited (ASX: PME)

Another note out of Bell Potter reveals that its analysts have upgraded this health imaging technology company's shares to a buy rating with an vastly improved price target of $330.00. This follows the release of another strong result from Pro Medicus this week. Bell Potter highlights that its full stack solution continues to wipe the floor with competitors. It notes that there have been 10 contract announcements in the last 12 months, including two new academic medical centres clients. The broker also notes that it expects further growth in the cardiology space with the first small scale implementation to take place in April. The Pro Medicus share price is fetching $284.80 at the time of writing.

Treasury Wine Estates Ltd (ASX: TWE)

Analysts at Goldman Sachs have retained their buy rating on this wine giant's shares with a slightly trimmed price target of $12.90. According to the note, the broker has reduced its sales and earnings forecasts slightly through to FY 2027 to reflect stronger Penfolds and Americas sales, offset by weaker Premium Brands sales. Outside this, Goldman points out that Treasury Wine's shares are trading on an FY 2026 P/E of just ~15x, which is inexpensive relative to its consumer coverage. And if it is able to demonstrate added comfort to the market on its Penfolds channel sell-through and sustained US luxury portfolio growth, it expects the stock to re-rate positively. The Treasury Wine share price is trading at $10.86 this afternoon.

Should you invest $1,000 in Amp Limited right now?

Before you buy Amp Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Amp Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor James Mickleboro has positions in Pro Medicus and Treasury Wine Estates. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two brokers analysing stocks.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A pilot stands in an empty passenger cabin smiling with his arms crossed looking excited
Broker Notes

Why Qantas shares could be a top buy in April

What are analysts saying about the Flying Kangaroo?

Read more »

A young man sits at his desk working on his laptop with a big smile on his face due to his ASX shares going up and in particular the Computershare share price
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares in focus: 3 key takeaways from Bunnings investor day

Here's what you need to know about the main event this week.

Read more »

A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

Broker says this ASX 200 share is a 'quality stock to put in your bottom drawer'

Ord Minnett has good things to say about this blue chip.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Down nearly 20% in 2 days: What is Macquarie saying about James Hardie shares?

Shares in ASX building materials giant James Hardie are falling after news of a major acquisition.

Read more »